The president of the ANA and the chair of the annual meeting programming committee provided perspective on the upcoming ANA Annual Meeting and what clinicians may get out of the meeting. [WATCH TIME: 7 minutes]
WATCH TIME: 7 minutes
"Within the next decade, how do we implement new changes in our treatments? What are we thinking about? What do we know about disparities in health care? These are things that we’re concerned about, educating the next generation of neurologists and keeping ourselves educated."
The 2023 American Neurological Association (ANA) Annual Meeting, the 148th running of the event, will take place September 9-12 at the Philadelphia Marriott Downtown in Philadelphia, Pennsylvania. The meeting will feature 6 main symposia, which highlight groundbreaking conceptual and therapeutic advances in a variety of neurologic disease states, as well as interactive lunch workshops, special interest group sessions, and the ANA’s celebrated poster sessions.
Considered one of the most respected organizations in the field, the ANA is home to the monthly Annals of Neurology, a prestigious medical journal, and the Annals of Clinical and Translational Neurology, an online-only, open access journal providing rapid dissemination of high-quality, peer-reviewed research. Since it was first started in 1875, the ANA has undergone some minor changes, expanding its membership in 2015 to include students and trainees to prepare the next generation of clinician-researchers for success.
Prior to the Annual Meeting, programming chair Rebecca Gottesman, MD, PhD, FANA, and Frances Jensen, MD, FACP, president of the ANA, sat down with NeurologyLive® to give an overview of the upcoming event. Gottesman, a senior investigator at the National Institutes of Neurological Disorders and Stroke, and Jensen, chair of the neurology department at the University of Pennsylvania Perelman School of Medicine, discussed the reasons as to why clinicians should attend the meeting, and what it may offer. The duo spoke about the various types of educational sessions, and why coverage of general neurology is important for the clinical community.